New Delhi: India's drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), will review the ceiling prices of knee implants at a meeting likely to be held next week.

The NPPA had capped prices of knee implants in 2017, bringing down the procedural expenses for patients by up to 70% by using extraordinary powers granted under the Drug Price Control Order (DPCO), 2013.

The NPPA had capped prices of knee implants in 2017, cutting costs for patients by up to 70%, using extraordinary powers under the Drug Price Control Order (DPCO) 2013.

The price cap, originally valid until September 15, has been extended to November 15 or until further orders.

Manufacturers and industry associations have made multiple representations, pushing for a permissible 10% price increase

See Full Page